Literature DB >> 20952466

Serum and urinary cell-free MiR-146a and MiR-155 in patients with systemic lupus erythematosus.

Gang Wang1, Lai-Shan Tam, Edmund Kwok-Ming Li, Bonnie Ching-Ha Kwan, Kai-Ming Chow, Cathy Choi-Wan Luk, Philip Kam-Tao Li, Cheuk-Chun Szeto.   

Abstract

OBJECTIVE: Recent studies showed that micro-RNA play important roles in the pathogenesis of autoimmune diseases. We studied the levels of miR-146a and miR-155 in the serum and urinary supernatant of patients with systemic lupus erythematosus (SLE).
METHODS: The serum and urinary supernatant levels of miR-146a and miR-155 were determined by real-time quantitative polymerase chain reaction in 40 patients with SLE and 30 healthy controls.
RESULTS: Compared to controls, serum miR-146a and miR-155 levels were lower, and the urinary level of miR-146a was higher, in SLE. Estimated glomerular filtration rate (eGFR) correlated with both serum miR-146a (r = 0.519, p = 0.001) and miR-155 (r = 0.384, p = 0.014). Serum miR-146a inversely correlated with proteinuria (r = -0.341, p = 0.031) and the SLE Disease Activity Index (r = -0.465, p = 0.003). Serum miR-146a and miR-155 levels also correlated with red blood cell count, platelet count, and lymphocyte count. After treatment with calcitriol for 6 months, serum miR-146a level of SLE patients increased significantly (p < 0.001), and its change inversely correlated with the level of calcium-phosphate product (r = -0.466, p = 0.003).
CONCLUSION: The results suggested that serum miR-146a and miR-155 participate in the pathophysiology of SLE and might be used as biomarkers of SLE.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20952466     DOI: 10.3899/jrheum.100308

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  59 in total

1.  miRNA-146a in rheumatoid arthritis: a new therapeutic strategy.

Authors:  Kaleb M Pauley; Seunghee Cha
Journal:  Immunotherapy       Date:  2011-07       Impact factor: 4.196

2.  Cellular and urinary microRNA alterations in NZB/W mice with hydroxychloroquine or prednisone treatment.

Authors:  Cristen B Chafin; Nicole L Regna; Sarah E Hammond; Christopher M Reilly
Journal:  Int Immunopharmacol       Date:  2013-10-09       Impact factor: 4.932

3.  Clinical relevance of plasma miR-21 in new-onset systemic lupus erythematosus patients.

Authors:  Zhao Ming Tang; Min Fang; Jin Ping Wang; Peng Cheng Cai; Ping Wang; Li Hua Hu
Journal:  J Clin Lab Anal       Date:  2014-03-22       Impact factor: 2.352

4.  Predicting microRNA-disease associations using bipartite local models and hubness-aware regression.

Authors:  Xing Chen; Jun-Yan Cheng; Jun Yin
Journal:  RNA Biol       Date:  2018-09-19       Impact factor: 4.652

Review 5.  MicroRNAs in IgA nephropathy.

Authors:  Cheuk-Chun Szeto; Philip K-T Li
Journal:  Nat Rev Nephrol       Date:  2014-04-08       Impact factor: 28.314

6.  Genetic association of miRNA-146a with systemic lupus erythematosus in Europeans through decreased expression of the gene.

Authors:  S E Löfgren; J Frostegård; L Truedsson; B A Pons-Estel; S D'Alfonso; T Witte; B R Lauwerys; E Endreffy; L Kovács; C Vasconcelos; B Martins da Silva; S V Kozyrev; M E Alarcón-Riquelme
Journal:  Genes Immun       Date:  2012-01-05       Impact factor: 2.676

7.  Biomarkers in systemic lupus erythematosus: challenges and prospects for the future.

Authors:  Chau-Ching Liu; Amy H Kao; Susan Manzi; Joseph M Ahearn
Journal:  Ther Adv Musculoskelet Dis       Date:  2013-08       Impact factor: 5.346

Review 8.  Genomic approaches in the search for molecular biomarkers in chronic kidney disease.

Authors:  M Cañadas-Garre; K Anderson; J McGoldrick; A P Maxwell; A J McKnight
Journal:  J Transl Med       Date:  2018-10-25       Impact factor: 5.531

Review 9.  MicroRNAs and autoimmunity.

Authors:  Angela Ceribelli; Minoru Satoh; Edward K L Chan
Journal:  Curr Opin Immunol       Date:  2012-08-14       Impact factor: 7.486

10.  A translational study of urine miRNAs in acute myocardial infarction.

Authors:  Yunhui Cheng; Xiaobin Wang; Jian Yang; Xiaoxia Duan; Yi Yao; Xiaoling Shi; Zhuang Chen; Zhongcai Fan; Xiaojun Liu; Shanshan Qin; Xiaojun Tang; Chunxiang Zhang
Journal:  J Mol Cell Cardiol       Date:  2012-08-19       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.